An upcoming appeal by Auden McKenzie, Allergan and other drug companies over antitrust fines imposed by the UK’s competition regulator should be heard in stages, a judge suggested today.
A handful of drugmakers are appealing more than 260 million pounds ($344 million) in sanctions imposed by the Competition and Markets Authority